SI1095064T1 - Amidi hialuronske kisline in njihovi derivati ter postopek njihove priprave - Google Patents
Amidi hialuronske kisline in njihovi derivati ter postopek njihove pripraveInfo
- Publication number
- SI1095064T1 SI1095064T1 SI9930816T SI9930816T SI1095064T1 SI 1095064 T1 SI1095064 T1 SI 1095064T1 SI 9930816 T SI9930816 T SI 9930816T SI 9930816 T SI9930816 T SI 9930816T SI 1095064 T1 SI1095064 T1 SI 1095064T1
- Authority
- SI
- Slovenia
- Prior art keywords
- group
- hyaluronic acid
- arylaliphatic
- cycloaliphatic
- aliphatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
- A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
- A61L24/043—Mixtures of macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/34—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/042—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT98PD000169A ITPD980169A1 (it) | 1998-07-06 | 1998-07-06 | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
PCT/IB1999/001254 WO2000001733A1 (en) | 1998-07-06 | 1999-07-06 | Amides of hyaluronic acid and the derivatives thereof and a process for their preparation |
EP99929619A EP1095064B1 (en) | 1998-07-06 | 1999-07-06 | Amides of hyaluronic acid and the derivatives thereof and a process for their preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1095064T1 true SI1095064T1 (sl) | 2005-12-31 |
Family
ID=11392271
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9930816T SI1095064T1 (sl) | 1998-07-06 | 1999-07-06 | Amidi hialuronske kisline in njihovi derivati ter postopek njihove priprave |
Country Status (14)
Country | Link |
---|---|
US (2) | US7884087B1 (sl) |
EP (2) | EP1589036A1 (sl) |
JP (3) | JP2002519481A (sl) |
AT (1) | ATE297413T1 (sl) |
AU (1) | AU761986B2 (sl) |
CA (1) | CA2339066C (sl) |
DE (1) | DE69925733T2 (sl) |
DK (1) | DK1095064T3 (sl) |
ES (1) | ES2244198T3 (sl) |
IL (2) | IL140604A0 (sl) |
IT (1) | ITPD980169A1 (sl) |
PT (1) | PT1095064E (sl) |
SI (1) | SI1095064T1 (sl) |
WO (1) | WO2000001733A1 (sl) |
Families Citing this family (136)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITPD980169A1 (it) | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
DE60107560T2 (de) * | 2000-05-03 | 2006-01-05 | FIDIA ADVANCED BIOPOLYMERS, S.R.L., Abano Terme | Preadipozyten enthaltende biomaterialien zur regeneration von weichgewebe |
IT1317359B1 (it) * | 2000-08-31 | 2003-06-16 | Fidia Advanced Biopolymers Srl | Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e |
KR100375299B1 (ko) * | 2000-10-10 | 2003-03-10 | 주식회사 엘지생명과학 | 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법 |
US7060297B2 (en) | 2000-11-06 | 2006-06-13 | Alcon, Inc. | Carrageenan viscoelastics for ocular surgery |
SV2003000753A (es) | 2000-12-05 | 2003-06-16 | Brigham & Womens Hospital | Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico |
ITPD20010032A1 (it) | 2001-02-09 | 2002-08-09 | Fidia Advanced Biopolymers Srl | Innesti ingegnerizzati per la riparazione di difetti osteocondrali |
US7923431B2 (en) | 2001-12-21 | 2011-04-12 | Ferrosan Medical Devices A/S | Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis |
JP2003190259A (ja) * | 2001-12-28 | 2003-07-08 | Hisako Ogawara | 人工臓器用チャンバー |
ITPD20020003A1 (it) * | 2002-01-11 | 2003-07-11 | Fidia Advanced Biopolymers Srl | Biomateriali a base di acido ialuronico come terapia anti-angiogenicanella cura dei tumori. |
ITPD20020064A1 (it) | 2002-03-12 | 2003-09-12 | Fidia Advanced Biopolymers Srl | Derivati esterei dell'acido ialuronico per la preparazione di idrogelda utilizzare in campo biomedico, sanitario e chirurgico e come sistem |
DE10393060D2 (de) * | 2002-05-09 | 2005-05-04 | Hemoteq Gmbh | Reduktion der Schallemission von dünnwadigen Bauteilen in Magnetresonazgeräten |
ITMI20021666A1 (it) * | 2002-07-26 | 2004-01-26 | Jasper Ltd Liability Co | Derivati dell'acido ialuronico |
ITPD20020271A1 (it) * | 2002-10-18 | 2004-04-19 | Fidia Farmaceutici | Composti chimico-farmaceutici costituiti da derivati dei taxani legati covalentemente all'acido ialuronico o ai suoi derivati. |
CA2503489C (en) * | 2002-10-25 | 2013-09-10 | Essentia Biosystems, Inc. | Modulation of zinc levels to improve tissue properties |
CN1739017B (zh) | 2002-12-11 | 2011-04-06 | 弗罗桑医疗设备公司 | 用作拭子的基于明胶的材料 |
WO2004060404A1 (ja) * | 2002-12-27 | 2004-07-22 | Chugai Seiyaku Kabushiki Kaisha | 薬物担体 |
US6982298B2 (en) | 2003-01-10 | 2006-01-03 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US8137688B2 (en) | 2003-01-10 | 2012-03-20 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US7465766B2 (en) | 2004-01-08 | 2008-12-16 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
US8138265B2 (en) | 2003-01-10 | 2012-03-20 | The Cleveland Clinic Foundation | Hydroxyphenyl cross-linked macromolecular network and applications thereof |
CA2520865A1 (en) | 2003-03-31 | 2004-10-21 | The Brigham And Women's Hospital, Inc. | Zwitterionic immunomodulators for the treatment of asthma and allergy |
EP1666518B1 (en) | 2003-09-08 | 2018-03-28 | Chugai Seiyaku Kabushiki Kaisha | Hyaluronic acid modification products and drug carriers using them |
WO2005054302A1 (ja) * | 2003-12-05 | 2005-06-16 | Chugai Seiyaku Kabushiki Kaisha | 薬物担体及びその製造方法 |
NZ549010A (en) * | 2004-01-07 | 2010-07-30 | Seikagaku Kogyo Co Ltd | Hyaluronic acid derivative and drug containing the same |
CN1921896B (zh) | 2004-01-30 | 2010-11-24 | 弗罗桑公司 | 止血喷雾剂和组合物 |
ITPD20040053A1 (it) * | 2004-02-27 | 2004-05-27 | Fidia Advanced Biopolymers Srl | Biomateriali costituiti da derivati dell'acido ialuronico come nuova terapia di cura per la protezione e la la riparazione della cartilagine articolare danneggiata per osteoartrosi |
ITMI20041373A1 (it) | 2004-07-09 | 2004-10-09 | Lima Lto S P A | N-metil-ammidi di carbossimetilcellulosa acido alginico o carbossimetalamido |
CN102382308B (zh) * | 2004-07-09 | 2014-04-16 | 克利夫兰临床基金会 | 羟基苯交联大分子网络及其应用 |
JP4959557B2 (ja) | 2004-07-09 | 2012-06-27 | フェロサン メディカル デバイシーズ エイ/エス | ヒアルロン酸含有止血合成剤 |
EP1790665B1 (en) * | 2004-09-07 | 2014-11-05 | Chugai Seiyaku Kabushiki Kaisha | Process for producing water-soluble modified hyaluronic acid |
ITPD20050056A1 (it) * | 2005-03-02 | 2006-09-03 | Fidia Farmaceutici | Derivati ammidici del'acido ialuronico in osteoartrosi |
JP4902134B2 (ja) * | 2005-04-25 | 2012-03-21 | 帝人株式会社 | 癒着防止材 |
ITPD20050206A1 (it) | 2005-07-07 | 2007-01-08 | Fidia Advanced Biopolymers Srl | Biomateriali in forma di fibra da impiegarsi come dispositivi medici nel trattamento delle ferite e loro processi di produzione |
US20080221063A1 (en) * | 2005-07-08 | 2008-09-11 | Astrazeneca Ab | Heterocyclic Sulfonamide Derivatives As Inhibitors Of Factor Xa |
ITPD20050242A1 (it) | 2005-08-03 | 2007-02-04 | Fidia Farmaceutici | Bioconiugati antitumorali dell'acido ialuronico o dei suoi derivati, ottenibili per coniugazione chimica diretta o indiretta, e loro impiego in campo farmaceutico |
CA2625532C (en) * | 2005-10-12 | 2013-10-01 | Seikagaku Corporation | Agent for applying to mucosa containing a hydrophobic group binding type glycosaminoglycan |
AU2012201314B2 (en) * | 2005-10-12 | 2014-04-10 | Seikagaku Corporation | Agent for applying to mucosa and method for production thereof |
US8206726B2 (en) | 2006-02-06 | 2012-06-26 | The Brigham And Women's Hospital, Inc. | Zwitterionic polysaccharides for promotion of immune system maturation and health |
AU2014200868B2 (en) * | 2006-12-06 | 2016-01-07 | Seikagaku Corporation | Pharmaceutical agent having long-lasting effect of treating arthritic disorders |
TWI528964B (zh) | 2006-12-06 | 2016-04-11 | 生化學工業股份有限公司 | 治療關節失調之長效藥劑 |
US8329870B2 (en) | 2007-01-04 | 2012-12-11 | Hepacore Ltd. | Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof |
CN101020725B (zh) * | 2007-03-23 | 2010-09-15 | 天津大学 | 一类双亲性壳聚糖长链烷基季铵盐及其制备方法 |
ITMI20071267A1 (it) | 2007-06-22 | 2008-12-23 | Fidia Farmaceutici | Uso di coniugati dell'acido ialuronico nel trattamento locale di malattie cutanee iperproliferative |
ITMI20071724A1 (it) | 2007-09-05 | 2009-03-06 | Fidia Farmaceutici | Formulazioni topiche antivirali in forma di gel bioadesivo |
JP2011503104A (ja) | 2007-11-09 | 2011-01-27 | カリフォルニア インスティテュート オブ テクノロジー | 免疫調節化合物ならびに関連組成物および方法 |
KR101577471B1 (ko) | 2007-11-16 | 2015-12-14 | 알러간, 인코포레이티드 | 자색반병의 치료를 위한 조성물 및 방법 |
US8394782B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
ITMI20072416A1 (it) | 2007-12-21 | 2009-06-22 | Sigea Srl | Derivati polisaccaridici dell'acido lipoico, loro preparazione ed uso come dermocosmetici e presidi medicali |
WO2009102967A2 (en) | 2008-02-13 | 2009-08-20 | The Cleveland Clinic Foundation | Molecular enhancement of extracellular matrix and methods of use |
EP2259803B2 (en) | 2008-02-29 | 2019-03-13 | Ferrosan Medical Devices A/S | Device for promotion of hemostasis and/or wound healing |
US8410180B2 (en) | 2008-04-30 | 2013-04-02 | The Cleveland Clinic Foundation | Methods to treat urinary incontinence |
US8450475B2 (en) | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
WO2010028025A1 (en) | 2008-09-02 | 2010-03-11 | Gurtner Geoffrey C | Threads of hyaluronic acid and/or derivatives thereof, methods of making thereof and uses thereof |
US8624077B2 (en) | 2008-10-02 | 2014-01-07 | L.R.R.&D. Ltd. | Interface layer wound dressing |
JP2010163485A (ja) * | 2009-01-13 | 2010-07-29 | Teijin Ltd | カルボキシ多糖類の溶液 |
EP2420517A4 (en) | 2009-04-17 | 2013-04-03 | Teijin Ltd | POLYSAC CHARID DERIVATIVE AND HYDROGEL THEREOF |
IT1399351B1 (it) | 2009-06-16 | 2013-04-16 | Fidia Farmaceutici | Procedimento per la sintesi di coniugati di glicosamminoglicani (gag) con molecole biologicamente attive, coniugati polimerici e usi relativi |
IT1394570B1 (it) | 2009-07-02 | 2012-07-05 | Fidia Farmaceutici | Materiale biologico adatto per la terapia dell osteoartrosi del danno dei legamenti e per il trattamento delle patologie delle articolazioni. |
IT1395392B1 (it) * | 2009-08-27 | 2012-09-14 | Fidia Farmaceutici | Geli viscoelastici come nuovi filler |
US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
CA2792729C (en) | 2010-03-12 | 2016-06-28 | Allergan Industrie, Sas | Fluid compositions for improving skin conditions |
DK2550027T4 (da) | 2010-03-22 | 2019-05-13 | Allergan Inc | Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse |
DK2555753T3 (en) | 2010-04-07 | 2018-11-26 | California Inst Of Techn | Vesicle for delivering a compound to a mucosal membrane as well as corresponding compositions, methods and systems |
CA2800174A1 (en) | 2010-05-20 | 2011-11-24 | June L. Round | Antigen specific tregs and related compositions, methods and systems |
WO2012008722A2 (ko) * | 2010-07-12 | 2012-01-19 | 신풍제약 주식회사 | 조직 증강용 충전 조성물 |
US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
CZ305040B6 (cs) | 2010-09-14 | 2015-04-08 | Contipro Biotech S.R.O. | Způsob přípravy vysoce substituovaných amidů kyseliny hyaluronové |
CN101972489A (zh) * | 2010-09-30 | 2011-02-16 | 吴奕光 | 一种新型创面自修复生物材料及其制备方法和用途 |
ES2385239B1 (es) | 2010-09-30 | 2013-06-19 | Proteos Biotech S.L.U. | Uso de colagenasa g recombinante, colagenasa h recombinante y pz-peptidasa recombinante para el tratamiento de enfermedades que cursan con alteraciones del colágeno. |
JP6141180B2 (ja) | 2011-03-03 | 2017-06-07 | 中外製薬株式会社 | アミノ−カルボン酸により修飾されたヒアルロン酸誘導体 |
WO2012140650A2 (en) | 2011-04-12 | 2012-10-18 | Hepacore Ltd. | Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof |
US20130096081A1 (en) | 2011-06-03 | 2013-04-18 | Allergan, Inc. | Dermal filler compositions |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
WO2012167079A2 (en) | 2011-06-03 | 2012-12-06 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US8658593B2 (en) | 2011-06-06 | 2014-02-25 | The Cleveland Clinic Foundation | Treatment of extracellular matrix to reduce inflammation |
US9539281B2 (en) | 2011-07-12 | 2017-01-10 | The Brigham And Women's Hospital, Inc. | Lipid-containing PSA compositions, methods of isolation and methods of use thereof |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
CA2865349C (en) | 2012-03-06 | 2021-07-06 | Ferrosan Medical Devices A/S | Pressurized container containing haemostatic paste |
JP6104232B2 (ja) | 2012-03-27 | 2017-03-29 | テルモ株式会社 | コーティング組成物および医療機器 |
WO2013146380A1 (ja) * | 2012-03-27 | 2013-10-03 | テルモ株式会社 | コーティング組成物および医療機器 |
WO2013146381A1 (ja) * | 2012-03-27 | 2013-10-03 | テルモ株式会社 | 薬剤コート層およびこれを有する医療機器 |
ITPD20120098A1 (it) | 2012-03-30 | 2013-10-01 | Fidia Farmaceutici | "nuove formulazioni faramaceutiche contenenti condroitin solfato e derivati dell'acido ialuronico" |
ITPD20120173A1 (it) * | 2012-05-31 | 2013-12-01 | Fidia Farmaceutici | "nuovo sistema di rilascio di proteine idrofobiche" |
RU2636240C2 (ru) | 2012-06-12 | 2017-11-21 | Ферросан Медикал Дивайсиз А/С | Сухая гемостатическая композиция |
US11564971B2 (en) | 2012-09-05 | 2023-01-31 | Chugai Seiyaku Kabushiki Kaisha | Hyaluronic acid derivative having amino acid and steryl group introduced thereinto |
CN103720712A (zh) * | 2012-10-10 | 2014-04-16 | 上海工程技术大学 | 一种制备季铵化壳聚糖纳米碘消毒剂的方法 |
CZ2012841A3 (cs) * | 2012-11-27 | 2014-02-19 | Contipro Biotech S.R.O. | Vlákna založená na hydrofobizovaném hyaluronanu, způsob jejich přípravy a použití, textilie na jejich bázi a použití |
JP6363119B2 (ja) * | 2013-03-14 | 2018-07-25 | アナコティ リミテッド | ヒアルロン酸誘導体 |
ITPD20130110A1 (it) | 2013-04-24 | 2014-10-25 | Fidia Farmaceutici | Composizioni farmaceutiche comprendenti acido ialuronico per il trattamento del black disc |
JP2016521284A (ja) | 2013-05-10 | 2016-07-21 | カリフォルニア インスティチュート オブ テクノロジー | 大腸ガンのプロバイオティクスによる防止および処置 |
RU2700162C2 (ru) | 2013-06-21 | 2019-09-13 | Ферросан Медикал Дивайсиз А/С | Расширенная под вакуумом сухая композиция и шприц для ее сохранения |
JP6357228B2 (ja) | 2013-07-10 | 2018-07-11 | マトリックス バイオロジー インスティテュート | 高い弾性を有するヒアルロナンの組成物およびその使用 |
US9572832B2 (en) * | 2013-08-29 | 2017-02-21 | Holy Stone Healthcare Co., Ltd. | Compound of glycosaminoglycan and its fabrication method as well as application |
US10047172B2 (en) | 2013-09-30 | 2018-08-14 | Galderma S.A. | Single step functionalization and cross-linking of hyaluronic acid |
WO2015048988A1 (en) | 2013-10-02 | 2015-04-09 | Ao Technology Ag | Thermosensitive hyaluronic acid conjugates and methods for the preparation thereof |
EP3079731B1 (en) | 2013-12-11 | 2018-08-08 | Ferrosan Medical Devices A/S | Dry composition comprising an extrusion enhancer |
CA3187647A1 (en) | 2014-06-15 | 2015-12-23 | Yeda Research And Development Co. Ltd. | Surface treatment by water-soluble polymers and lipids/liposomes |
CZ2014451A3 (cs) * | 2014-06-30 | 2016-01-13 | Contipro Pharma A.S. | Protinádorová kompozice na bázi kyseliny hyaluronové a anorganických nanočástic, způsob její přípravy a použití |
ES2761558T3 (es) | 2014-09-30 | 2020-05-20 | Allergan Ind Sas | Composiciones de hidrogel estables que incluyen aditivos |
BR112017007466B1 (pt) | 2014-10-13 | 2021-03-02 | Ferrosan Medical Devices A/S | método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca |
WO2016102446A1 (en) | 2014-12-24 | 2016-06-30 | Ferrosan Medical Devices A/S | Syringe for retaining and mixing first and second substances |
JP6613300B2 (ja) * | 2015-03-31 | 2019-11-27 | キユーピー株式会社 | ヒアルロン酸誘導体およびその製造方法、ならびにヒアルロン酸誘導体を含む化粧料、食品組成物および医薬組成物 |
US11331335B2 (en) | 2015-06-10 | 2022-05-17 | California Institute Of Technology | Sepsis treatment and related compositions methods and systems |
CA2986981A1 (en) | 2015-07-03 | 2017-01-12 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
CN108135167B (zh) | 2015-08-19 | 2021-07-09 | 哈佛学院院长及董事 | 脂化psa组合物和方法 |
EP3842047A1 (en) | 2015-09-24 | 2021-06-30 | Matrix Biology Institute | High elasticity hyaluronan compositions and methods of use thereof |
EP3252082A1 (en) * | 2016-05-31 | 2017-12-06 | Galderma S.A. | Method for deacetylation of biopolymers |
BR112018013523B1 (pt) | 2015-12-29 | 2022-06-14 | Galderma S.A. | Produto de hidrogel compreendendo moléculas de glicosaminoglicano reticuladas e processo para preparação de um produto de hidrogel |
EP3448394B1 (en) | 2016-04-27 | 2023-09-13 | Anika Therapeutics, Inc. | Compositions for use in treating tendon degeneration |
PT3623390T (pt) | 2016-05-31 | 2023-10-27 | Galderma Sa | Reticulador de hidrato de carbono |
EP3484441A4 (en) | 2016-07-15 | 2020-03-18 | President and Fellows of Harvard College | GLYCOLIPID COMPOSITIONS AND METHODS OF USE |
WO2018024902A1 (en) * | 2016-08-04 | 2018-02-08 | Biokawthar Technologies | Uses of hydrophobically-modified hyaluronic acid through amide and/or hydrazide linkages in cosmetics and/or dermatology |
CZ2016826A3 (cs) | 2016-12-22 | 2018-07-04 | Contipro A.S. | Léčivý prostředek s nosičem na bázi hyaluronanu a/nebo jeho derivátů, způsob výroby a použití |
CN110891611B (zh) | 2017-03-22 | 2024-03-29 | 阿森迪斯制药公司 | 水凝胶交联透明质酸前药组合物和方法 |
IT201700122135A1 (it) * | 2017-10-26 | 2019-04-26 | Jointherapeutics S R L | Acido ialuronico funzionalizzato o suo derivato nel trattamento di stati infiammatori |
WO2020144372A1 (en) | 2019-01-10 | 2020-07-16 | The Provost, Fellows, Scholars And Other Members Of Board Of Trinity College Dublin | Composite viscoelastic hydrogel, and uses thereof for sealing a channel in tissue |
CA3087820A1 (en) | 2018-01-10 | 2019-07-18 | The Provost, Fellows, Scholars And Other Members Of Board Of Trinity College Dublin | System and methods for sealing a channel in tissue |
IT201800001890A1 (it) * | 2018-01-25 | 2019-07-25 | Fidia Farm Spa | Composizioni farmaceutiche per il trattamento del dolore postoperatorio |
IT201900006250A1 (it) | 2019-04-23 | 2020-10-23 | Fidia Farm Spa | Medicazione per il trattamento della cute lesa |
KR20210008479A (ko) | 2018-05-09 | 2021-01-22 | 훼로산 메디칼 디바이스 에이/에스 | 지혈 조성물을 제조하는 방법 |
KR102240726B1 (ko) * | 2019-01-31 | 2021-04-16 | 주식회사 에스엔비아 | 방사성 동위원소가 표지된 광가교성 하이드로젤 및 그 제조 방법 |
WO2020181356A1 (en) * | 2019-03-08 | 2020-09-17 | Queen's University At Kingston | Hyaluronic acid derivatives for wound healing |
CN109762078B (zh) * | 2019-04-09 | 2019-07-23 | 中国科学院烟台海岸带研究所 | 一种羟丙基三甲基氯化铵壳聚糖-羧基多糖复合盐及制备方法和应用 |
IT201900006038A1 (it) | 2019-04-18 | 2020-10-18 | Fidia Farm Spa | Composizioni farmaceutiche comprendenti statine e derivati dell’acido ialuronico |
JP2022529953A (ja) * | 2019-04-19 | 2022-06-27 | ジョインセラピュイティクス エッセ.エッレ.エッレ. | 官能化ヒアルロン酸の架橋ポリマーと、炎症状態の治療におけるその使用 |
WO2020240034A1 (en) | 2019-05-31 | 2020-12-03 | University College Dublin | Hyaluronic acid-based hybrid hydrogel |
IT201900009933A1 (it) | 2019-06-24 | 2020-12-24 | Fidia Farm Spa | Composizioni farmaceutiche comprendenti derivati ammidici dell'acido ialuronico per uso nel trattamento di traumi ossei, in particolare in pazienti con problemi di osteopenia o osteoporosi |
CN110760014A (zh) * | 2019-11-19 | 2020-02-07 | 恩施徕福硒业有限公司 | 一种从茯苓中提取硒多糖的提取装置及工艺 |
US11730691B2 (en) | 2019-12-02 | 2023-08-22 | Galderma Holding SA | High molecular weight esthetic compositions |
IT202000005692A1 (it) | 2020-03-17 | 2021-09-17 | Fidia Farm Spa | Bio-inchiostro per stampa 3D, relativo coniugato e processo di preparazione di un intermedio costituito da un linker fotoreattivo |
IT202100032111A1 (it) | 2021-12-22 | 2023-06-22 | Fidia Farm Spa | Nuovi sostituti biocompatibili dell’umor vitreo |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55161801A (en) * | 1979-06-06 | 1980-12-16 | Seikagaku Kogyo Co Ltd | Fluorescence-labeled acid mucopolysaccharide and preparation thereof |
US4851521A (en) | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
US6174999B1 (en) * | 1987-09-18 | 2001-01-16 | Genzyme Corporation | Water insoluble derivatives of polyanionic polysaccharides |
US4937270A (en) | 1987-09-18 | 1990-06-26 | Genzyme Corporation | Water insoluble derivatives of hyaluronic acid |
IT1217458B (it) | 1988-05-02 | 1990-03-22 | Crinos Ind Farmacoriologica S | Sulfoamino derivati di condroitin solfati,del dermatan solfato e dell' acido ialuronico e loro proprieta' farmacologiche |
US5510418A (en) | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
JPH0755961B2 (ja) | 1989-04-18 | 1995-06-14 | 工業技術院長 | 新規なヒアルロン酸誘導体及びその製造方法 |
EP0416250A3 (en) | 1989-08-01 | 1991-08-28 | The Research Foundation Of State University Of New York | N-acylurea and o-acylisourea derivatives of hyaluronic acid |
US5733891A (en) * | 1990-10-18 | 1998-03-31 | Shiseido Co., Ltd. | Compound for medicinal ingredient and hyaluronic acid and process for producing the same |
CA2070672C (en) | 1990-10-18 | 2002-10-08 | Kazuo Akima | Compound of medicinal ingredient and hyaluronic acid and process for producing the same |
JP2855307B2 (ja) * | 1992-02-05 | 1999-02-10 | 生化学工業株式会社 | 光反応性グリコサミノグリカン、架橋グリコサミノグリカン及びそれらの製造方法 |
US5612360A (en) * | 1992-06-03 | 1997-03-18 | Eli Lilly And Company | Angiotensin II antagonists |
IT1260154B (it) * | 1992-07-03 | 1996-03-28 | Lanfranco Callegaro | Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn) |
IT1263316B (it) * | 1993-02-12 | 1996-08-05 | Fidia Advanced Biopolymers Srl | Tessuto non tessuto multistrato in cui uno degli strati e' costituito essenzialmente da esteri dell'acido ialuronico |
IT1268955B1 (it) * | 1994-03-11 | 1997-03-18 | Fidia Advanced Biopolymers Srl | Esteri attivi di polisaccaridi carbossilici |
CA2162957C (en) | 1994-11-17 | 2011-08-02 | Michinori Waki | Cinnamic acid derivative |
IT1281876B1 (it) * | 1995-05-10 | 1998-03-03 | Fidia Advanced Biopolymers Srl | Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci. |
JP4018181B2 (ja) | 1995-11-07 | 2007-12-05 | 生化学工業株式会社 | グリコサミノグリカン誘導体およびその製造法 |
JP3047801B2 (ja) | 1995-12-20 | 2000-06-05 | 株式会社日立製作所 | プラズマ処理方法及び装置 |
JP3925955B2 (ja) | 1996-04-26 | 2007-06-06 | 株式会社クラレ | 癒着防止材 |
JP3955652B2 (ja) | 1996-10-15 | 2007-08-08 | 株式会社ネーテック | 合成アミノ糖類誘導体及びその製造方法 |
JPH10298164A (ja) * | 1997-02-27 | 1998-11-10 | Tanabe Seiyaku Co Ltd | イソキノリノン誘導体、その製法及びその合成中間体 |
CA2285542C (en) * | 1997-04-04 | 2007-07-17 | Fidia Advanced Biopolymers Srl | N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
JP3410476B2 (ja) * | 1997-04-18 | 2003-05-26 | 大鵬薬品工業株式会社 | 新規なエポキシコハク酸アミド誘導体又はその塩 |
GB9710990D0 (en) * | 1997-05-28 | 1997-07-23 | Danisco | Modification process |
ITPD980169A1 (it) | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
IT1303735B1 (it) | 1998-11-11 | 2001-02-23 | Falorni Italia Farmaceutici S | Acidi ialuronici reticolati e loro usi medici. |
KR100375299B1 (ko) | 2000-10-10 | 2003-03-10 | 주식회사 엘지생명과학 | 히알루론산의 가교결합형 아마이드 유도체와 이의 제조방법 |
KR20040009891A (ko) | 2002-07-26 | 2004-01-31 | 주식회사 엘지생명과학 | 히알루론산의 유도체 겔 및 그 제조방법 |
-
1998
- 1998-07-06 IT IT98PD000169A patent/ITPD980169A1/it unknown
-
1999
- 1999-07-06 DK DK99929619T patent/DK1095064T3/da active
- 1999-07-06 CA CA2339066A patent/CA2339066C/en not_active Expired - Lifetime
- 1999-07-06 ES ES99929619T patent/ES2244198T3/es not_active Expired - Lifetime
- 1999-07-06 EP EP05011126A patent/EP1589036A1/en not_active Withdrawn
- 1999-07-06 JP JP2000558133A patent/JP2002519481A/ja active Pending
- 1999-07-06 EP EP99929619A patent/EP1095064B1/en not_active Expired - Lifetime
- 1999-07-06 AT AT99929619T patent/ATE297413T1/de active
- 1999-07-06 AU AU46397/99A patent/AU761986B2/en not_active Expired
- 1999-07-06 PT PT99929619T patent/PT1095064E/pt unknown
- 1999-07-06 IL IL14060499A patent/IL140604A0/xx unknown
- 1999-07-06 WO PCT/IB1999/001254 patent/WO2000001733A1/en active IP Right Grant
- 1999-07-06 US US10/220,853 patent/US7884087B1/en not_active Expired - Fee Related
- 1999-07-06 DE DE69925733T patent/DE69925733T2/de not_active Expired - Lifetime
- 1999-07-06 SI SI9930816T patent/SI1095064T1/sl unknown
-
2000
- 2000-12-28 IL IL140604A patent/IL140604A/en not_active IP Right Cessation
-
2006
- 2006-09-20 JP JP2006254511A patent/JP4791921B2/ja not_active Expired - Lifetime
-
2009
- 2009-11-20 US US12/623,253 patent/US8575129B2/en not_active Expired - Fee Related
-
2011
- 2011-04-07 JP JP2011085601A patent/JP2011174079A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
ATE297413T1 (de) | 2005-06-15 |
WO2000001733A1 (en) | 2000-01-13 |
CA2339066C (en) | 2012-04-03 |
JP2011174079A (ja) | 2011-09-08 |
AU761986B2 (en) | 2003-06-12 |
US8575129B2 (en) | 2013-11-05 |
EP1589036A1 (en) | 2005-10-26 |
ES2244198T3 (es) | 2005-12-01 |
ITPD980169A1 (it) | 2000-01-06 |
JP2007031721A (ja) | 2007-02-08 |
PT1095064E (pt) | 2005-10-31 |
DK1095064T3 (da) | 2005-10-03 |
CA2339066A1 (en) | 2000-01-13 |
JP2002519481A (ja) | 2002-07-02 |
DE69925733D1 (de) | 2005-07-14 |
IL140604A0 (en) | 2002-02-10 |
JP4791921B2 (ja) | 2011-10-12 |
US7884087B1 (en) | 2011-02-08 |
EP1095064A1 (en) | 2001-05-02 |
AU4639799A (en) | 2000-01-24 |
DE69925733T2 (de) | 2006-03-16 |
EP1095064B1 (en) | 2005-06-08 |
US20100158796A1 (en) | 2010-06-24 |
IL140604A (en) | 2010-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL140604A0 (en) | Amides of hyaluronic acid and the derivatives thereof and a process for their preparation | |
DK0731085T3 (da) | Stilbenderivater og farmaceutiske sammensætinger indeholdende disse | |
ES8802494A1 (es) | Procedimiento para la obtencion de derivados de acidos benzoheterociclilalcanoicos | |
ZA918893B (en) | Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,process for their production and pharmaceutical agents containing these derivatives | |
CA2086654A1 (en) | Novel pharmaceutically active 1,2,4-triaminobenzene derivatives, processes for their preparation and pharmaceutical compositions containing them | |
FI950309A0 (fi) | Proliiniamidijohdannaisia | |
HUP0004853A2 (hu) | Hepatitis C inhibitor peptidek, eljárás ezek előállítására, azokat tartalmazó gyógyszerkészítmények, alkalmazásuk és intermediereik | |
HUT64842A (en) | Method for producing pharmaceutical preparatives containing 2-[n-(2-amino-ethyl)-amino]-acetic acid derivatives | |
AU2505297A (en) | Acylated N-hydroxymethyl thalidomide prodrugs having an immunomodulatory effect | |
MX9705559A (es) | Derivados de acido neuraminico, su preparacion y su uso en medicina. | |
DE69624582D1 (de) | Ester und amide als pla2-inhibitoren | |
HK1040237A1 (en) | Fused polycyclic amino acids as pharmaceutical agents. | |
MX9605737A (es) | Transfeccion de celulas. | |
PH24709A (en) | Allylmercaptoacetylsydnonimines and pharmaceutical compositions thereof | |
DE69429753T2 (de) | Anitbiotisch wirksame Cephalosporine und Verfahren zu ihrer Herstellung | |
ES2189323T3 (es) | Procedimiento para la preparacion de 3-amino-2-oxo-pirrolidinas, productos intermedios y su utilizacion. | |
AU2630095A (en) | Novel amine derivative, process for producing the same, and use thereof as antiarrhythmic | |
IL95619A0 (en) | N-azabicyclo(3.3.0)octane amides of aromatic acids and pharmaceutical compositions containing them | |
CA2277151A1 (en) | Synthesis of acyclic nucleoside derivatives | |
CA2251060A1 (en) | Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action | |
IT1276710B1 (it) | Derivati dell'acido fosfinico ad attivita' inibitrice delle metallopeptidasi | |
HUP9903414A2 (en) | 3-alkoxypyridine-2-carboxylic acid amide esters,their preparation and their use as drugs | |
EP0826663A3 (en) | Alkynylamino acid derivatives and their use as pharmaceutical compounds |